Monday, 21 December 2020

Covaxin Crosses Half-Way Mark In Phase-3 Trials, Says Bharat Biotech

India's first and only phase III trial of a COVID-19 vaccine has crossed 13,000 subjects - the half-way mark - and proceeding successfully across multiple sites in India, Bharat Biotech, the maker of...

from NDTV News - India-news https://ift.tt/3rtOTBw
at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

6 Killed After Pickup Vehicle Carrying Milk Plunges Into Gorge In Shimla

Six people were killed after a pickup vehicle carrying milk plunged into a deep gorge in the Urman area under Taklech police outpost in Hima...